¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength Tylenol Flu Day Non-Drowsy Gelcaps"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë±â¿ï±â¼¼±â, ÃÖ´ë°æ»ç°­µµ
  • avian flu
    Á¶·ùÀÎÇ÷翣ÀÚ
  • flu
    Ç÷ç, ÀÎÇ÷翣ÀÚ
  • intestinal flu
    âÀÚÇ÷ç, Àå°üÇ÷ç
  • swine flu
    µÅÁöÀÎÇ÷翣ÀÚ
  • day blindness
    ÁÖ°£½Ã°¢»ó½Ç, ÁÖ°£¸Í
  • day care
    ÁÖ°£µ¹º½, ÁÖ°£°£È£
  • day hospital
    ³·º´¿ø
  • day residue
    ÁÖ°£ÀÜÀç
  • day surgery
    Åë¿ø¼ö¼ú, ÁÖ°£¼ö¼ú
  • egg per day per female
    ¾ÏÄÆÇÏ·ç»ê¶õ¼ö
  • egg per day per worm
    ÃæÃ¼ÇÏ·ç»ê¶õ¼ö
  • five day fever
    ¿ÀÀÏ¿­, ÂüÈ£¿­
  • mean solar day
    Æò±ÕžçÀÏ
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum dose
    ÃÖ´ë¿ë·®, ÃÖ´ë¼±·®
  • maximum
    ÃÖ´ë
  • scatter-maximum ratio
    ÃÖ´ë»ê¶õºñ
  • strength
    Èû, ¼¼±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • physical strength
    ü·Â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tylenol
    ŸÀÌ·¹³î
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • flu
    Ç÷ç, ÀÎÇ÷翣ÀÚ
  • intestinal flu
    âÀÚÇ÷ç, Àå°üÇ÷ç
  • swine flu
    µÅÁöÀ¯Çà°¨±â
  • alternating day strabismus
    °ÝÀÏ»ç½Ã
  • day blindness
    ÁÖ°£¸Í, ÁÖ°£½Ã°¢»ó½Ç
  • day care
    ÁÖ°£µ¹º½
  • day-night cycle
    ³·¹ãÁÖ±â
  • infant day care
    ¿µ¾ÆÁÖ°£°¡·á
  • day
    ÀÏ
  • day hospital
    ³·º´¿ø
  • day residue
    ÁÖ°£ÀÜÀç
  • day surgery
    ¿Ü·¡¼ö¼ú, Åë¿ø¼ö¼ú
  • mean solar day
    Æò±ÕžçÀÏ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Riley Day syndrome
    ¸±¸®-µ¥ÀÌÁõÈıº.
  • alternate day esotropia
    °ÝÀϳ»»ç½Ã
  • alternating day strabismus
    °ÝÀÏ»ç½Ã
  • fracture strength
    ÆÄÀý °­µµ.
  • fracture strength
    ÆÄÀý°­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • infant day care
    ¿µ¾Æ ÁÖ°£ °¡·á
  • physical strength
    ü·Â(ô÷æ³).
  • MAC=> maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ.
  • MBC=£¾maximum breathing capacity
    ÃÖ´ëÈ£Èí(¿ë)·®, ÃÖ´ëȯ±â·®.
  • MTD=> maximum toderance dose
    ÃÖ´ë³»¿ë·®.
  • MTD=£¾maximum tolerance dose
    ÃÖ´ë³»¿ë·®.
  • MVV=>maximum voluntary ventilation
    ÃÖ´ë ¼öÀÇȯ±â·®
  • Tm => transport maximum
    ÃÖ´ëÀ̵¿Ä¡
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • day-to-day variation
    ÀÏÀϺ¯µ¿Ä¡
  • tylenol
    ŸÀÌ·¹³î
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • flu-like syndrome
    µ¶°¨À¯»ç ÁõÈıº
  • intestinal flu
    Àå°üÇ÷ç.
  • swine flu
    µÅÁöÀ¯Ç༺°¨±â
  • alternate day esotropia
    °ÝÀϳ»»ç½Ã
  • alternating day strabismus
    °ÝÀÏ»ç½Ã
  • day blindness
    ÁÖ(°£)¸Í
  • day care
    ÁÖ°£(ñ¸Êà)µ¹º½
  • day hospital
    ³·º´¿ø.
  • day hospital
    ³·º´¿ø
  • day residue
    ÁÖ°£ÀÜÀç(ñ¸ÊàíÑî«)
  • day surgery
    ¿Ü·¡¼ö¼ú, Åë¿ø¼ö¼ú.
  • day-night cycle
    ¹ã³·ÁÖ±â(ñ¸Ñ¢)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg per day per female
    ¾ÏÄÆÇÏ·ç»ê¶õ¼ö
  • egg per day per worm
    ÃæÃ¼ÇÏ·ç»ê¶õ¼ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bond strength
    °áÇÕ·Â(Ì¿ùêÕô)
  • dipole strength
    ½Ö±ØÀÚ(äªÐ¿í­) ¼¼±â
  • eluent strength
    ¿ë¸®(éÁ×î) ¼¼±â
  • ionic strength
    À̿ °­µµ(Ë­Óø)
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • maximum permissible body burden
    ÃÖ´ëü³»Çã¿ëºÎ´ã(õÌÓÞô÷Ò®úÉé»Ý¶Ó½)
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ(õÌÓÞúÉé»ÒØÓø)
  • maximum permissible dose
    ÃÖ´ëÇã¿ë·®(õÌÓÞúÉé»Õá)
  • maximum stationary phase
    ÃÖ´ëÁ¤Áö±â(õÌÓÞïÎò­Ñ¢)
  • maximum velocity
    ÃÖ´ë¼Óµµ(õÌÓÞáÜÓø)
  • promoter strength
    ÇÁ·Î¸ðÅÍ °­µµ(Ë­Óø)
  • rotational strength
    ȸÀü(üÞï®) ¼¼±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • maximum
    ÃÖ´ë, ÃÖ°í
  • maximum intensity projection
    ÃÖ´ë°­µµÅõ»ç
  • maximum permissible dose [=MPD]
    ÃÖ´ëÇã¿ë(¼±)·®
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
US/LS upper strength/lower strength [ratio]
Flu, Flue inFluenzae; °¨±â
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Day 0 day as
Day 1 day
DAY 1 day of birth
3H-FLU 3H-Flunitrazepam
FLU 3H-flunitrazepam
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
  • alternate day esotropia
    °ÝÀÏ ³»»ç½Ã
  • day-vision
    ÁÖ°£½Ã
  • lunar day
    ÅÂÀ½ÀÏ
    ´ÞÀÇ »è¸ÁÁֱ⸦ ÇÑ ´ÞÀÇ ±âÁØÀ¸·Î ÇÏ´Â ¿ª. ÀϹÝÀûÀ¸·Î´Â ¼øÅÂÀ½·ÂÀ» ¸»ÇÏ´Â °ÍÀÌ ¾Æ´Ï°í ÅÂÀ½Å¾ç·ÂÀ» ÁöÀûÇÑ´Ù. ¼øÅÂÀ½·Â¿¡¼­´Â À±´ÞÀ» ÀüÇô µÎÁö ¾ÊÀ¸¹Ç·Î ¿ªÀϰú °èÀýÀÌ Á¡Â÷ ´Þ¶óÁ®¼­ 5,6¿ù¿¡ ´«ÀÌ ¿À±âµµ Çϰí Á¤¿ù°ú 2¿ù¿¡ Ȥ¼­°¡ µÇ±âµµ ÇÏÁö¸¸, ÅÂÀ½Å¾ç·Â¿¡¼­´Â °£°£ÀÌ À±´ÞÀ» µÒÀ¸·Î½á ¿ªÀϰú °èÀýÀÌ ¸¹ÀÌ ¾î±ß³ªÁö ¾Ê°Ô ÇÏ¿´´Ù. ÇöÀç °ø½ÄÀûÀ¸·Î´Â À½·Â, Áï ÅÂÀ½Å¾ç·ÂÀÌ ¾²ÀÌÁö ¾ÊÁö¸¸, ¹Î°£¿¡¼­´Â ¿©ÀüÈ÷ ¾ç·Â°ú ¾Æ¿ï·¯ À½·ÂÀÌ ¾²À̰í ÀÖ´Ù. À½·ÂÀÇ ±âÁØÀº ´ÙÀ½°ú °°´Ù. ¨ç žç°ú ´Þ°úÀÇ ÁøÈ²°æÀÌ °°Àº ½Ã°¢À» »èÀ¸·Î ÇÑ´Ù. ¨è žçÀÇ ÁøÈ²°æÀÌ 0¡Æ, 30¡Æ, 60¡Æ,¡¦ÀÎ ¶§¸¦ Áß±â·Î ÇÑ´Ù. ¨é Çѱ¹¿¡¼­ÀÇ ¸Å ¿ªÀÏÀÇ ½ÃÀÛÀº Çѱ¹ Ç¥ÁؽÃÀÇ ¹ã 0½ÃºÎÅÍ ½ÃÀ۵ȴÙ. ¨ê ÇÕ»èÀÌ µéÀº ³¯Àº À½·Â ¸Å¿ù ÃÊÇÏ·ç·Î Á¤ÇÑ´Ù. ¨ë Á߱⸦ °¡ÁöÁö ¾Ê´Â ´ÞÀ» À±´Þ·Î ÇÑ´Ù. ½Å¶ó½Ã´ëÀÇ Àδö·Â, ¹éÁ¦ÀÇ ¿ø°¡·Â, °í·ÁÀÇ ¼±¸í·Â°ú ´ëÅë·Â, Á¶¼±½Ã´ëÀÇ ½ÃÇå·Â µî ¸ðµÎ ÅÂÀ½Å¾ç·ÂÀÌ´Ù. ÀÌ·± °ÍÀ» °£´ÜÈ÷ À½·ÂÀ̶ó°í ¸»ÇÑ´Ù. °ú°Å¿¡ Çѱ¹¿¡¼­´Â À½·Â¸¸ ½á¿À´Ù°¡ °íÁ¾ÀÇ Á¶Ä¢¿¡ ÀÇÇÏ¿© 1896³â 1¿ù 1ÀϺÎÅÍ Å¾ç·ÂÀ» ¾²°Ô µÇ¾ú´Ù.
  • Riley Day syndrome
    ¸±¸®µ¥ÀÌ ÁõÈıº
    Conrad Milton Riley, ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç, 1913³â»ý. Richard Lawrence Day, ¹Ì±¹ÀÇ ¼Ò¾Æ°ú ÀÇ»ç, 1905³â»ý.
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
  • marginal strength
    º¯¿¬ °­µµ, ¿¬´Ü °­µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
vaccine, flu The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
stomach flu A misnomer that has nothing to do with influenza (flu) virus, the term stomach flu is sometimes used to describe gastrointestinal illnesses caused by other microorganisms.
(12 Dec 1998)
immunization, flu The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers taking aspirin therapy (and who may therefore be at risk for developing reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
immunization, h. flu See Immunization, HIB.
(12 Dec 1998)
flu A lay term that describes a illness that is characterised by fever, malaise, weakness and muscle aches. An infection caused by the influenza virus.
(27 Sep 1997)
flu shot A special vaccine which provides immunity to infection by a variety of Influenza viruses. The vaccine is updated annually due to the constant introduction of new viral strains. Flu vaccination programs are common in the elderly population and any other groups who are at increased risk of viral infection.
(27 Sep 1997)
flu shots The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone age 65 or more; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers receiving long-term aspirin therapy (and who may therefore be at risk for developing Reye syndrome after an influenza virus infection), people in close or frequent contact with anyone at high risk. People with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
flu, stomach A misnomer that has nothing to do with influenza (flu) virus, the term stomach flu is sometimes used to describe gastrointestinal illnesses caused by other microorganisms.
(12 Dec 1998)
flu vaccine The flu (influenza) vaccine is recommended for persons at high risk for serious complications from influenza infection, including everyone 65 or over; people with chronic diseases of the heart, lung or kidneys, diabetes, immunosuppression, or severe forms of anaemia; residents of nursing homes and other chronic-care facilities, children and teenagers on long-term aspirin therapy (and who may therefore be at risk for developing Reye syndrome after an influenza infection), and those in close or frequent contact with anyone at high risk. Persons with an allergy to eggs should not receive influenza vaccine.
(12 Dec 1998)
maximum 1. The greatest possible or actual effect or quantity.
2. The acme of a disease or process.
(18 Nov 1997)
maximum breathing capacity The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.).
Synonym: maximum breathing capacity.
(05 Mar 2000)
maximum occipital point The point on the squama of the occipital bone farthest from the glabella.
(05 Mar 2000)
maximum permissible dose <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime.
This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large.
(05 Mar 2000)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
maximum temperature In bacteriology, denoting a temperature above which growth will not take place.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Hong Kong flu
    È«Äá µ¶°¨
  • flu
    ÀÎÇ÷翣ÀÚ;À¯Ç༺ °¨±â;µ¶°¨
  • hog flu
    µÅÁöÀÇ À¯Ç༺ °¨±â
  • intestinal flu
    ¼³»ç¸¦ ÀÏÀ¸Å°´Â À¯Ç༺ °¨±â
  • maximum
    ÃÖ´ë; ÃÖ°í; ±ØÇÑ
  • strength
    Èû,¼¼·Â,ÀåÁ¡
  • field strength
    ÀåÀÇ ¼¼±â;Àü°è °­µµ
  • impact strength
    (Àç·áÀÇ)Ãæ°Ý °­µµ
  • maximum
    ÃÖ´ëÇѵµ
  • maximum dose
    (¾àÀÇ) ±Ø·®
  • maximum permissible dosage
    (¹æ»ç´É) ÃÖ´ë Çã¿ë Á¶»ç Àû·®
  • maximum thermometer
    ÃÖ°í ¿Âµµ°è
  • radio field intensity (strength)
    ÀüÆÄ °­µµ;ÀüÀÚÀå °­µµ
  • strength
    Èû;°­Çϱâ;°­µµ;³óµµ;º´·Â;È¿·Â;ÀúÇ×(³»±¸)·Â;ÈûÀÌ µÇ´Â °Í;ÀÇÁö;on the ~ of;...À» ÀÇÁöÇÏ¿©(¹Ð°í)
  • day by day
    ³¯¸¶´ÙÀÇ;¸ÅÀÏÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á